Showing 891-900 of 5314 results for "".
Viora Marketing Summary 2010
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/viora-marketing-summary-2010-/19450/Various Doctors give their opinions on the benefits of using Viora for Cellulite Treatment, Circumferential Reduction and Skin Tightening for the Face & Body.Dermatology and CTCL: Recommendations
https://practicaldermatology.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatologHS Tips and Lizards
https://practicaldermatology.com/series/the-practical-dermatology-podcast/hs-tips-and-lizards/35858/The latest news and updates, plus a psoriasis update from Jashin J. Wu, MD, FAAD, at Music City SCALE, and Jennifer L. Hsiao, MD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss treating hidradenitis suppurativa and play a game of "Two Truths and a Lie."When and How to Use Ancillary Testing
https://reachmd.com/programs/practical-dermatology-updates-in-skin-cancer/when-and-how-to-use-ancillary-testing/35598/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses when a dermatopathologist decides to use ancillary testing for melanoma, how that impacts final diagnosis, and how it can guide treatment decisions.Journal Scan of Three Trials for an Rx Option
https://practicaldermatology.com/topics/psoriasis/deucravacitinib-journal-scan/29155/A review of three clinical trials, with introduction and commentary by Linda Stein Gold, MD. Click the image to download the full supplement.PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
https://practicaldermatology.com/topics/psoriasis/psa-5t-ds-a-new-psoriatic-arthritis-assessment-tool/20227/The PsA 5-Thermometer Scale Domains (PsA-5T-Ds) measures patient-reported pain, fatigue, physical function, skin problems, and depression. Here, Philip Mease, MD, discusses the validity of this tool in three Phase 3 studies of guselkumab as well as the role it could play in practice.Scale 2023: Exclusive Preview from Music City
https://practicaldermatology.com/topics/practice-management/music-city-sound/20184/Michael Gold, MD, gives a sneak peek of the exciting agenda for the upcoming Music City SCALE 2023 meeting.Why is CSF Different?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-is-csf-different/20124/Discover why CSF is different from other meetings. Attendees and faculty share their CSF experience and describe why they think the meeting and its new Nashville home make for “a great program.”What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.Injectable Safety
https://practicaldermatology.com/conferences/maui-derm-2022/injectable-safety/20272/When using fillers in the face, it's important to think about the anatomy beneath the skin, says Joel L. Cohen, MD. He stresses the importance of going beyond text book and cartoon drawings of anatomy, which might not be complete, and thinking about cadaver studies to ensure a complete understanding